Best Promising Stocks To Buy For 2014

Being a StreetAuthority subscriber has privileges. That includes learning firsthand about our biggest breakthroughs.

I want to let you know about one such discovery. It's likely to be one of the most groundbreaking finds in our company's history and could completely change the way you invest.

We're still finalizing the research, but the results are promising. It's a new method that has produced average annual gains of 21.4% during the past decade, compared with the S&P's 7.1% a year.

 

I'll tell you more in just a moment, but first I want to reintroduce you to the man behind this research -- Michael J. Carr.

You may have heard from Mike recently in this article.

Mike is one of our brightest experts here at StreetAuthority. He also has one of the most interesting backgrounds of any analyst on our staff.

Hot Healthcare Technology Stocks To Buy For 2015: Cameco Corporation(CCJ)

Cameco Corporation operates as a uranium producer, supplier of conversion services, and fuel manufacturer. The company?s Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. Its operating uranium properties include the McArthur River and Key Lake, and Rabbit Lake located in Saskatchewan, Canada; the Crow Butte located in Nebraska and the Smith Ranch-Highland located in Wyoming; and the Inkai uranium deposit located in Kazakhstan. Cameco Corporation?s Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate; and the purchase and sale of conversion services. Its products include uranium trioxide, uranium hexafluoride, and uranium dioxide. This segment also manufactures fuel bundles, reactor components, and monitoring equipment to Candu reactors; and provides nuclear fuel and consulting services to Candu operators. The company?s Electricity segment engages in the generation and sale of nuclear electricity, through its 31.6% interest in Bruce Power L.P. This segment operates four nuclear reactors at the Bruce B generating station in southern Ontario, Canada. The company was founded in 1987 and is headquartered in Saskatoon, Canada.

Advisors' Opinion:

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, uranium producer Cameco (NYSE: CCJ  ) has earned a respected four-star ranking.

• [By Dividend]

  Cameco (CCJ) has a market capitalization of $7.64 billion. The company employs 3,470 people, generates revenue of $2.234 billion and has a net income of $254.68 million. Cameco�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $704.68 million. The EBITDA margin is 31.54 percent (the operating margin is 11.60 percent and the net profit margin 11.40 percent).

Best Promising Stocks To Buy For 2014: Bwin.Party Digital Entertainment PLC (BPTY)

bwin.party digital entertainment plc (bwin.party) is a holding company. The Company is an online gaming company. It operates in five segments: sports betting, casino & games, poker, bingo; and other (including network services, World Poker Tour, InterTrader.com, WIN.com, software services and the payment services business). Its sport betting segment includes bwin, betoto, Gamebookers, Gioco Digitale and PartyBets. It�� Casino & games segment includes PartyCasino, bwin and GD Casino. Its poker segment includes PartyPoker, bwin and GD Casino. Its Bingo segment includes Foxy Bingo, Cheeky Bingo, Gioco Digitale and Binguez. The Company�� subsidiaries include BES SAS, bwin Argentina SA, bwin Italia S.r.l., bwin.party Games AB and Cashcade Limited. Its subsidiaries are engaged in management and information technology (IT) services, marketing services, online gaming, transaction services, customer support services, marketing support services and Land-based poker events. Advisors' Opinion:

• [By Namitha Jagadeesh]

  Bwin.Party Digital Entertainment Plc (BPTY) plunged 14 percent to 110 pence, the biggest drop since April 2011, after the online gaming company said 2013 sales will be 14 percent to 17 percent lower than last year�� figures. Analysts on average had forecast a sales drop of 9.2 percent.

Best Promising Stocks To Buy For 2014: Planar Systems Inc.(PLNR)

Planar Systems, Inc., together with its subsidiaries, engages in developing, manufacturing, and marketing electronic display products and systems. The company provides customized, embedded, and ruggedized displays to original equipment manufacturers and other system suppliers; and active-matrix liquid crystal display panels for use in various applications and industries, including instrumentation, medical equipment, vehicle dashboards, indoor and outdoor digital signage, and military applications. It also offers liquid crystal display (LCD) video walls and rear-projection cube video walls for use in venue digital signage, as well as in various control room installations under the Clarity brand name. In addition, the company provides LCD based displays, including desktop monitors, touch displays, widescreen monitors, and front-projection equipment to the information technology market. Further, it offers home theater front-projection video systems, video processing equipment , large-format thin video displays, ?window wall? video applications, and accessories primarily to custom home installation dealers under the Runco brand name. Planar Systems, Inc. operates in the United States, the United Kingdom, Finland, Germany, Italy, France, Turkey, the United Arab Emirates, Kuwait, India, Taiwan, and China. The company was founded in 1983 and is headquartered in Beaverton, Oregon.

Advisors' Opinion:

• [By Konrad Kuhn]

  Founded in 1983, Planar Systems (PLNR) is a global leader in display and digital signage technology; retailers, educational institutions, government agencies, utilities, energy firms, and home theater enthusiasts all depend on Planar when image experience is the highest importance.

Best Promising Stocks To Buy For 2014: Stein Mart Inc.(SMRT)

Stein Mart, Inc. operates retail stores that offer fashion merchandise for women and men in the United States. The company?s stores provide fashion apparel, accessories, shoes, and home fashions. As of April 19, 2011, it operated a chain of 263 retail stores. The company was founded in 1908 and is headquartered in Jacksonville, Florida.

Advisors' Opinion:

• [By David Trainer]

  Unfortunately, FVL's holdings don't look likely to out-perform. 67% of its capital is in stocks with a Dangerous-or-worse rating. Only 12% of its assets are in Attractive-or-better rated stocks. Its holdings include recent Danger Zone picks Rite Aid (RAD), Citigroup (C), and Stein Mart (SMRT). FVL's holdings get their worst scores on valuation.

• [By Reuters]

  Joshua Lott/Getty Images NEW YORK -- Several major U.S. retailers posted disappointing sales for November after cautious shoppers pinched their pennies at the start of a shorter holiday season. Some of the companies that reported sales gains ramped up bargains to bring in shoppers who appeared hesitant to splurge. Costco Wholesale (COST) said Thursday that sales at stores open at least a year rose 2 percent, below the 3.3 percent increase analysts were looking for, according to Thomson Reuters. The warehouse club chain said consumer electronics sales fell. Same-store sales at L Brands (LTD), owner of the Victoria's Secret lingerie chain, also came in below expectations. Its drop of 5.5 percent was far deeper than the 1.1 percent decline analysts were projecting. Wall Street analysts are expecting 11 top retailers to report a 2.7 percent increase in same-store sales for November, according to Thomson Reuters. Excluding drugstore operators, which get two-thirds of revenue from prescriptions, that gain is estimated at 2.3 percent. Gap (GPS) will report its November sales after U.S. markets close. Retailers have been contending with low consumer confidence and the need to prod shoppers with bargains this holiday season, which has six fewer days because of a late Thanksgiving. The National Retail Federation on Sunday said U.S. shoppers had spent 2.9 percent less this year over the Thanksgiving weekend, the kickoff to the holiday season. The Conference Board, an industry group, said last week that U.S. consumer confidence fell in November after a sharp drop in October as Americans worried about their future jobs and earnings prospects. Earlier this week, J.C. Penney (JCP) reported a 10.1 percent comparable sales increase, partially reversing a disastrous decline in 2012, but the department store chain had to resort to aggressive bargains. The "environment will remain as competitive" through the holiday season, Chief Executive Officer Myron Ullman said. I

• [By Marc Bastow]

  National retail chain Stein Mart (SMRT) raised its quarterly dividend 50% to 7.5 cents per share payable July 18 to shareholders of record July 3.
  SMRT Dividend Yield: 2.3%

• [By CRWE]

  Stein Mart, Inc. (Nasdaq:SMRT) reported comparable store sales for the four-week period ended August 25, 2012 increased 5.6 percent. Total sales for the period were $79.0 million, an increase of 6.9 percent from $73.9 million in the same period in 2011.

Best Promising Stocks To Buy For 2014: Omnicare Inc (OCR)

Omnicare, Inc. (Omnicare) is a healthcare services company. The Company operates in two primary businesses: Long-Term Care Group (LTC) and Specialty Care Group (SCG). Through LTC, Omnicare provides pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. SCG provides commercialization services for the biopharmaceutical industry in addition to end-of-life pharmaceutical care management for hospice care agencies. At December 31, 2011, LTC provided its pharmacy services in 47 states in the United States, the District of Columbia and in Canada. In September 2012, Five Star Quality Care, Inc. sold its pharmacy business to Omnicare.

Long-Term Care Group

Omnicare operates the institutional pharmacy business in North America. LTC's customers consist of skilled nursing facilities (SNFs), assisted living facilities (ALFs), independent living communities, hospitals, correctional facilities, and other healthcare service providers. LTC consisted of approximately 83% of the Company�� total net sales during the year ended December 31, 2011 and dispensed approximately 115.1 million prescriptions. The Company provides pharmacy consulting, including monthly patient drug therapy evaluations, assist in compliance with state and federal regulations and provide clinical and health management programs (utilizing outcomes-based algorithm technology). LTC also provides a range of technology solutions based on its Omniview Web-based platform.

LTC also provides a range of other products and services, including intravenous medications and nutrition products (infusion therapy products and services), respiratory therapy services, medical supplies and equipment (including billing the Medicare Part B program for eligible patients) and clinical care planning. It also provides pharmaceutical case management services for retirees, employees and dependents. The Company purchases, repackages and dispenses presc! ription and non-prescription medication in accordance with physician orders and deliver such prescriptions to long-term care facilities for administration to individual residents (by the facilities��nursing staff for SNFs).

The Company services long-term care facilities typically within a radius of approximately 150 miles of its pharmacy locations and maintain an around-the-clock, seven-day per week, on-call pharmacist service for emergency dispensing and delivery, and for consultation with the facility's staff or attending physician. The Company utilizes a unit-of-use drug distribution system. This means that its prescriptions are packaged for dispensing in individual doses. The Company�� range of technologies allow Web-based access to electronic medical records, automated pharmacy billing, online medication refills and returns processing, census tracking, pre-admission medication assessment and access to the Omnicare Guidelines.

Specialty Care Group

SCG serves the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its services are based on five platforms: brand support services, third party logistics, patient assistance programs, specialty pharmacy and disease management for end-of-life care. In the Company�� specialty pharmacy platform, it provides dispensing of specialized pharmaceuticals. These specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology and growth hormones. In its end-of-life care platform, Omnicare provides hospice care pharmaceutical management. SCG accounted for approximately 17% of the Company�� total net sales during 2011.

Omnicare competes with PharMerica Corporation.

Advisors' Opinion:

• [By Marc Bastow]

  Healthcare services provider Omnicare (OCR) raised its quarterly dividend 43% to 20 cents per share, payable on Dec. 24 to shareholders of record as of Dec. 16.
  OCR Dividend Yield: 1.36%

• [By Benjamin Shepherd]

  The American long-term care industry has been growing rapidly and will continue doing so for years to come. According to a study from the US Department of Health and Human Services, more than 70 percent of Americans over the age of 65 will need long-term care services at some point in their lives. Anyone over the age of 65 has a 40 percent chance of entering a nursing home and about 20 percent of them will remain there for at least five years.
  
  The size of the 65 and older population jumped by more than 15 percent between 2000 and 2010, compared to just 9.7 percent growth in the population as a whole. That group now makes up about 13 percent of the total population and is forecast to account for more than 16 percent by the end of this decade and 20.2 percent by 2050.
  
  Those trends have spurred huge runs for real estate investment trusts (REIT) that operate assisted-living facilities, rehabilitation centers and nursing homes across the country. While the senior living REITs have been an extremely profitable play on America�� graying population, their tide is ebbing with the prospect of rising interest rates creating fears that their profitability will be dinged. That creates opportunities for value investors focused on long-term returns, but it means short-term volatility.
  
  In this context, one compelling investment now is Omnicare (NYSE: OCR), a company that provides pharmacy services to long-term care and other medical facilities. Omnicare receives prescription orders from physicians at facilities, reviews them for effectiveness and any potential interactions with other drugs the patient is receiving and then prepares the drugs in specialized individual packages for easy administration.
  
  Omnicare has consultant pharmacists who can regularly review patient charts for potential interactions and duplications or to recommend alternative drugs or formulations that can increase the effectiveness of a patient�� medications, while also potent

Best Promising Stocks To Buy For 2014: Raymond James Financial Inc (RJF)

Raymond James Financial, Inc. (RJF) is a financial services holding company whose subsidiaries are engaged in various financial services businesses predominantly in the United States of America and Canada. At September 30, 2011, its principal subsidiaries include Raymond James & Associates, Inc. (RJ&A), Raymond James Financial Services, Inc. (RJFS), Raymond James Financial Services Advisors, Inc. (RJFSA), Raymond James Ltd. (RJ Ltd.), Eagle Asset Management, Inc. (Eagle), and Raymond James Bank, FSB (RJ Bank). All of these subsidiaries are wholly owned by RJF. In April 1, 2011, the Company acquired Howe Barnes Hoefer & Arnett (Howe Barnes). The Company operates through eight business segments: Private Client Group, Capital Markets, Asset Management, RJ Bank, Emerging Markets, Securities Lending, Proprietary Capital and various corporate activities combined in the Other segment. In April 2012, Regions Financial Corporation sold Morgan Keegan & Company, Inc. and related affiliates to RJF.

PRIVATE CLIENT GROUP

The Company provides securities transaction and financial planning services to approximately two million client accounts through the branch office systems of RJ&A, RJFS, RJFSA, RJ Ltd. and Raymond James Investment Services Limited (RJIS), a joint venture in the United Kingdom. Its financial advisors offer a range of investments and services, including both third-party and products, and a variety of financial planning services. The Company charges sales commissions or asset-based fees for investment services it provides to its Private Client Group clients based on established schedules. Varying discounts may be given, generally based upon the client's level of business, the trade size, service level provided, and other relevant factors. During the fiscal year ended September 30, 2011 (fiscal 2011), the portion of revenues from this segment that the Company considers recurring include sources, such as asset-based fees, including mutual fund and annuity trailing commissions, ! and interest income and represented approximately 61% of the Private Client Group's total revenues. Its financial advisors offer a number of professionally managed load mutual funds, as well as a selection of no-load funds. RJ&A and RJFS maintain dealer sales agreements with distributors of mutual fund shares sold through broker-dealers.

The Company�� principal subsidiary, RJ&A, is the full service brokerage and investment firm headquartered in the state of Florida and with over 220 locations throughout the United States, is a retail brokerage firms in the country. RJ&A is a self-clearing broker-dealer engaged in most aspects of securities distribution, trading, investment banking and asset management. RJ&A also offers financial planning services for individuals and provides clearing services for RJFS, RJFSA, other affiliated entities and several unaffiliated broker-dealers. RJFS is an independent contractor brokerage firms in the United States., is a member of Financial Industry Regulatory Authority (FINRA) and Securities Investors Protection Corporation (SIPC), but is not a member of any exchanges. Financial advisors affiliated with RJFS may offer their clients all products and services offered through RJ&A, including investment advisory products and services which are offered through its affiliated registered investment advisor, RJFSA. RJ Ltd. is its Canadian broker-dealer subsidiary, which is engaged in both retail and institutional distribution and investment banking. RJ Ltd. is a member of the Toronto Stock Exchange (TSX) and the Investment Industry Regulatory Organization of Canada (IIROC). Its United States broker-dealer subsidiary is a member of FINRA and SIPC.

CAPITAL MARKETS

Capital Markets activities consist primarily of equity and fixed income products and services. Its institutional clients are serviced by institutional equity departments of RJ&A and RJ Ltd.; the RJ&A fixed income department; RJ&A�� European offices; Raymond James Financial Intern! ational, ! Ltd, an institutional UK broker-dealer, and Raymond James European Securities, Inc., a joint venture, in which the Company hold a controlling interest. The Company charges commissions on equity transactions based on trade size and the amount of business conducted annually with each institution. Fixed income commissions are based on trade size and the characteristics of the specific security. Some European and United States offices also provide services to high net worth clients. RJ Ltd. has approximately 40 institutional equity sales and trading professionals servicing predominantly Canadian, United States and European institutional investors from offices in Canada and Europe.

Trading equity securities involves the purchase and sale of securities from and to its clients or other dealers. RJ&A makes markets in over 900 common stocks. The RJ Ltd. trading desks not only support client activity, but also take positions that are closely monitored within well defined limits. RJ Ltd. also provides specialist services in approximately 150 TSX listed common stocks. RJ&A trades both taxable and tax-exempt fixed income securities. The taxable and tax-exempt RJ&A fixed income traders purchase and sell corporate, municipal, government, government agency, and mortgage-backed bonds, asset-backed securities, preferred stock and certificates of deposit from and to its clients or other dealers.

Fixed income investment banking includes debt underwriting and public finance activities. The syndicate department consists of professionals who coordinate the marketing, distribution, pricing and stabilization of lead and co-managed equity underwritings. In addition to lead and co-managed offerings, this department coordinates the firm's syndicate and selling group activities in transactions managed by other investment banking firms. Raymond James Tax Credit Funds, Inc. (RJTCF) is the general partner or managing member in a number of limited partnerships and limited liability companies. These partnershi! ps and li! mited liability companies invest in real estate project entities that qualify for tax credits under Section 42 of the Internal Revenue Code.

ASSET MANAGEMENT

The Company�� Asset Management segment includes the operations of Eagle, the Eagle Family of Funds (Eagle Funds), the asset management operations of RJ&A (AMS), Raymond James Trust, and other fee-based programs. The majority of the revenue for this segment is generated by the investment advisory fees related to asset management services for individual investment portfolios and mutual funds. Investment advisory fees are also earned on assets held in managed and non-managed programs. Eagle Fund Distributors, Inc. (EFD), a wholly owned subsidiary of Eagle, is a registered broker-dealer engaged in the distribution of the Eagle Funds. The Eagle Funds utilize unaffiliated sub-advisors for the Capital Appreciation Fund and International Equity Fund. The Small Cap Growth Fund, Mid Cap Growth Fund, Growth and Income Fund, Large Cap Core Fund, Mid Cap Stock Fund, Investment Grade Bond Fund, and Small Cap Core Value Fund are managed by Eagle.

AMS

AMS manages several investment advisory programs which maintain an approved list of investment managers, provide asset allocation model portfolios, establish custodial facilities, monitor performance of client accounts, provide clients with accounting and other administrative services, and assist investment managers with certain trading management activities. In addition, AMS offers additional managed accounts managed within fee based asset allocation platforms under its Freedom accounts and other managed programs. Freedom�� investment committee manages portfolios of mutual funds, exchange traded funds and separately managed account models on a discretionary basis. AMS also provides certain services for their non-managed fee-based programs (Passport, Ambassador and other non-managed programs). They provide performance reporting, research, sales, accounting, trad! ing and o! ther administrative services. Client fees are based on the individual account or relationship size and may also be dependent on the type of securities in the accounts.

Raymond James Trust, National Association, (RJT) provides personal trust services primarily to existing clients of its broker-dealer subsidiaries. Portfolio management of trust assets can be subcontracted to its asset management operations. This subsidiary had a total of approximately $2 billion in client assets at September 30, 2011, including nearly $120 million in the donor-advised charitable foundation known as the Raymond James Charitable Endowment Fund.

RJ BANK

RJ Bank is a federally chartered savings bank, regulated by the Office of the Comptroller of the Currency (OCC), which provides corporate, residential and consumer loans, as well as Federal Deposit Insurance Corporation (FDIC) insured deposit accounts, to clients of our broker-dealer subsidiaries and to the general public. RJ Bank is active in corporate loan syndications and bank participations as well as purchases residential whole loan packages to hold for investment. RJ Bank generates revenue principally through the interest income earned on loans and investments, which is offset by the interest expense it pays on client deposits and on its borrowings.

RJ Bank�� assets include C&I loans, commercial and residential real estate loans, as well as consumer loans that were purchased or originated by RJ Bank. Corporate loans represent approximately 75% of RJ Bank�� loan portfolio of which 90% are Shared National Credits (SNC) or other large syndicated loans. RJ Bank purchases and originates corporate loans secured by corporate assets, commercial and industrial (C&I) loans, commercial and residential real estate loans, as well as consumer loans, all of which are funded primarily by cash balances swept from the investment accounts of our broker-dealer subsidiaries��clients.

EMERGING MARKETS

Raymond! James In! ternational Holdings, Inc. (RJIH), through its subsidiaries, has interests in operations in Latin American countries including Argentina, Uruguay and Brazil. Through these entities it operates securities brokerage, investment banking, asset management and equity research businesses. In fiscal 2011, approximately 75% of this segments��investment banking revenues arose from one client.

SECURITIES LENDING

This segment conducts its business through the borrowing and lending of securities from and to other broker-dealers, financial institutions and other counterparties. The Company conducts these activities as an intermediary. Securities Lending will also loan customer marginable securities held in a margin account containing a debit to counterparties. The borrower of the securities puts up a cash deposit on which interest is earned. The lender in turn receives cash and pays interest. These cash deposits are adjusted daily to reflect changes in the current market value of the underlying securities. Additionally, securities are borrowed from other broker-dealers to facilitate RJ&A�� clearance and settlement obligations. The net revenues of this securities lending business are the interest spreads generated.

PROPRIETARY CAPITAL

This segment consists of its principal capital and private equity activities, including various direct and third-party private equity and merchant banking investments; Raymond James Employee Investment Funds I and II (the EIF Funds), and a private equity fund which we sponsor-Raymond James Capital Partners, L.P. As of September 30, 2011, certain of its merchant banking investments include an investment in a manufacturer of crime investigation and forensic supplies, an event photography business, and an indirect investment in an allergy immunotherapy testing and treatment supply company.

Advisors' Opinion:

• [By Eric Volkman]

  The joint book-running managers of the issue are Raymond James Financial (NYSE: RJF  ) unit Raymond James & Associates, Royal Bank of Canada's (NYSE: RY  ) RBC Capital Markets, and the Securities divisions of Credit Suisse and Deutsche Bank (NYSE: DB  ) . The sale is expected to close on May 28.

Best Promising Stocks To Buy For 2014: Galectin Therapeutics Inc (GALT)

Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company's product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company's product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source.

GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.

Advisors' Opinion:

• [By Roberto Pedone]

   

  Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday's trading session.

   

  Monday's Volume: 674,000
  
  Three-Month Average Volume: 222,171
  
  Volume % Change: 149%

   

  Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.

   

   

  From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday's high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.

   

  Traders should now look for long-biased trades in GALT as long as it's trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.